MON-722 - GLP-1 and GLP-1/GIP Receptor Agonist Medication Use and Self-Reported Outcomes in Individuals with Lipedema: Results from A Large Online Survey

Abstract Poster Presenter(s)

• AS

  Ashok Srinivasan, Ph.D

  New York, NY, United States

Co-Author(s)

• LH

  Laura Harmacek, PhD

  Lipedema Foundation
  New York, New York, United States
• JK

  Jonathan Kartt, MA

  Lipedema Foundation
  New York, New York, United States
• SG

  Stephanie Galia, MPH

  Lipedema Foundation
  New York, New York, United States
• ES

  Elena Samouhos, MBA

  Lipedema Foundation
  New York, New York, United States
• SH

  Stacey Heil, MS, MBA

  Lipedema Foundation
  New York, New York, United States
• EC

  Erin Clark, BA

  Lipedema Foundation
  New York, New York, United States
• CM

  Courtney Mascio, OT/L, CLT

  Lipedema Foundation
  New York, New York, United States
• JC

  Jesse Cochrane, PhD

  Lipedema Foundation
  New York, New York, United States
• KG

  Kasi Grosvenor, MBA

  Lipedema Foundation
  New York, New York, United States